MedPath

SEA PHARMA CONSULTANCY PTE. LTD.

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

18

HSA:18

Drug Approvals

ENCORT TABLET 10MG

Approval Date
May 19, 2025
HSA

CLOPISWIFT FILM-COATED TABLET 75MG

Approval Date
Oct 30, 2024
HSA

QCIN CAPSULE 150 MG

Approval Date
Jul 18, 2024
HSA

HARUFEN PLASTER 30MG

Approval Date
Mar 21, 2022
HSA

ENTEVIR FILM-COATED TABLET 1MG

Approval Date
Oct 28, 2020
HSA

ENTEVIR FILM-COATED TABLET 0.5MG

Approval Date
Oct 28, 2020
HSA

PREBALIN CAPSULE 75MG

Approval Date
May 15, 2020
HSA

PREBALIN CAPSULE 150MG

Approval Date
May 15, 2020
HSA

PREBALIN CAPSULE 25MG

Approval Date
May 15, 2020
HSA

DEPREVIX MODIFIED RELEASE HARD CAPSULE 150MG

Approval Date
Aug 8, 2018
HSA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.